Multi-Center Studies. Pfizer may end Study Subject enrollment early by written notice to Institution if the total enrollment needed for a multi-center Study has been achieved before the end of the enrollment period for that Study or before Institution has enrolled the minimum number of Study Subjects.
Appears in 1 contract
Sources: Master Clinical Study Agreement
Multi-Center Studies. Pfizer may end Study Subject enrollment early by written notice to Institution if the total enrollment needed for a multi-center Study study has been achieved before the end of the enrollment period for that this Study or before Principal Investigator and Institution has (through the actions of the Principal Investigator) have enrolled the minimum number of Study Subjects.
Appears in 1 contract
Sources: Clinical Study Agreement
Multi-Center Studies. Pfizer may end Study Subject enrollment early by written notice to Institution if the total enrollment needed for a multi-center Study study has been achieved before the end of the enrollment period for that this Study or before Principal Investigator and Institution has (through the actions of the Principal Investigator) have enrolled the minimum number of Study Subjects.”.
Appears in 1 contract
Sources: Clinical Study Agreement